References
- Atta-Ur-Rahman A, Choudhary MI, Parvez K, et al. (2000). Quinolizidine alkaloids from Sophora alopecuroides. J Nat Prod 63:190–2.
- Ding PL, Yu YQ, Chen DF. (2005). Determination of quinolizidine alkaloids in Sophora tonkinensis by HPCE. Phytochem Anal 16:257–63.
- Ericsson T, Sundell J, Torkelsson A, et al. (2014). Effects of artemisinin antimalarials on cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies. Xenobiotica 44:615–26.
- Gao Y, Jiang W, Dong C, et al. (2012). Anti-inflammatory effects of sophocarpine in LPS-induced RAW 264.7 cells via NF-κB and MAPKs signaling pathways. Toxicol in Vitro 26:1–6.
- Gao Y, Li G, Li C, et al. (2009). Anti-nociceptive and anti-inflammatory activity of sophocarpine. J Ethnopharmacol 125:324–9.
- Grimm SW, Einolf HJ, Hall SD, et al. (2009). The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of America. Drug Metab Dispos 37:1355–70.
- Han Y, Zhou Y, Liu Q. (2006). [Antiendotoxic effects of Sophora alopecuroides L]. Zhong Yao Cai 29:1066–9.
- Hu X, Huang W, Yang Y. (2015). Cytochrome P450 isoenzymes in rat and human liver microsomes associate with the metabolism of total coumarins in Fructus cnidii. Eur J Drug Metab Pharmacokinet 40:373–7.
- Ito K, Iwatsubo T, Kanamitsu S, et al. (1998). Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport. Annu Rev Pharmacol Toxicol 38:461–99.
- Jeong HU, Kong TY, Kwon SS, et al. (2013). Effect of honokiol on cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes. Molecules 18:10681–93.
- Lang J, Li W, Zhao J, Wang K, Chen D. (2016). Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes. Xenobiotica 47:849–855.
- Lee SY, Lee JY, Kang W, et al. (2013). Cytochrome P450-mediated herb-drug interaction potential of Galgeun-tang. Food Chem Toxicol 51:343–9.
- Li AP. (2001). Screening for human ADME/Tox drug properties in drug discovery. Drug Discov Today 6:357–66.
- Lim YP, Chen WC, Cheng CH, et al. (2014). Inhibition of cytochrome P450 2C9 expression and activity in vitro by allyl isothiocyanate. Planta Med 80:1097–106.
- Liu T, Qian G, Wang W, Zhang Y. (2015). Molecular docking to understand the metabolic behavior of GNF-351 by CYP3A4 and its potential drug-drug interaction with ketoconazole. Eur J Drug Metab Pharmacokinet 40:235–8.
- Meng Q, Liu K. (2014). Pharmacokinetic interactions between herbal medicines and prescribed drugs: focus on drug metabolic enzymes and transporters. Curr Drug Metab 15:791–807.
- Pandit S, Mukherjee PK, Ponnusankar S, et al. (2011). Metabolism mediated interaction of α-asarone and Acorus calamus with CYP3A4 and CYP2D6. Fitoterapia 82:369–74.
- Peng Y, Wu H, Zhang X, et al. (2015). A comprehensive assay for nine major cytochrome P450 enzymes activities with 16 probe reactions on human liver microsomes by a single LC/MS/MS run to support reliable in vitro inhibitory drug-drug interaction evaluation. Xenobiotica 45:961–77.
- Qi XY, Liang SC, Ge GB, et al. (2013). Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes. Food Chem Toxicol 56:392–7.
- Song CY, Shi J, Zeng X, et al. (2013). Sophocarpine alleviates hepatocyte steatosis through activating AMPK signaling pathway. Toxicol in Vitro 27:1065–71.
- Song CY, Zeng X, Chen SW, et al. (2011). Sophocarpine alleviates non-alcoholic steatohepatitis in rats. J Gastroenterol Hepatol 26:765–74.
- Sun S, Zhang H, Sun F, et al. (2014). Intestinal transport of sophocarpine across the Caco-2 cell monolayer model and quantification by LC/MS. Biomed Chromatogr 28:885–90.
- Wrighton SA, Stevens JC. (1992). The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol 22:1–21.
- Wu YJ, Chen JJ, Cheng YY. (2005). A sensitive and specific HPLC-MS method for the determination of sophoridine, sophocarpine and matrine in rabbit plasma. Anal Bioanal Chem 382:1595–600.
- Yan Z, Caldwell GW. (2001). Metabolism profiling, and cytochrome P450 inhibition and induction in drug discovery. Curr Top Med Chem 1:403–25.
- Zhang H, Ya G, Rui H. (2016). Inhibitory effects of triptolide on human liver cytochrome P450 enzymes and P-glycoprotein. Eur J Drug Metab Pharmacokinet 42:89–98.
- Zhang JW, Liu Y, Cheng J, et al. (2007). Inhibition of human liver cytochrome P450 by star fruit juice. J Pharm Pharm Sci 10:496–503.
- Zhou SF. (2008). Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Curr Drug Metab 9:310–22.